New stroke drug aims to stop clots without causing bleeding
Disease control
Recruiting now
This study is testing whether adding an experimental drug called TBO-309 improves outcomes for stroke patients undergoing a specific procedure. The drug is given during surgery to open blocked arteries in the neck and brain, with the goal of preventing new clots from forming in t…
Phase: PHASE2 • Sponsor: ThromBio Pty. Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC